Wegovy HD (7.2 mg): Who It's For, Results and Cost

Wegovy HD is the same weekly semaglutide shot you may already know, at 7.2 mg instead of 2.4 mg. The FDA approved it on March 19, 2026, for adults who need more weight loss than the standard top dose gives them¹.

It is not a new drug and not a starting dose. It is the next step after 2.4 mg, and that changes who should consider it.

What is Wegovy HD?

Wegovy HD is a single-dose pen that delivers 7.2 mg of semaglutide once a week³. The FDA cleared it 54 days after Novo Nordisk filed, the fourth approval under the agency's new National Priority Voucher program¹.

Loss figures are the STEP UP results counting everyone who started, whether or not they stayed on the drug².

Who qualifies for 7.2 mg?

You need three things, per the label³:

1. 1.An adult with obesity, or overweight with at least one weight-related condition.
2. 2.At least four weeks on 2.4 mg that you tolerated.
3. 3.A prescriber who judges that more weight loss is clinically needed.

Teens stay at 2.4 mg or lower; their label stops there³.

In my experience, the people who ask about HD are the ones who hit a plateau on 2.4 mg. That's a fair reason to raise it. But check the basics first, protein, sleep and dose timing, because a plateau isn't always a dose problem. Our weight-loss plateau guide walks through what to rule out.

How do you get from 0.25 mg to 7.2 mg?

You climb the standard ladder first. Each step lasts four weeks, then you stay at 2.4 mg for at least four more before HD is an option³.

Week 21 is the earliest point. Many people stay longer at 2.4 mg, and that's fine. For how each step usually feels, see our Wegovy dose escalation schedule.

How much more weight do people lose on 7.2 mg?

About three percentage points more than on 2.4 mg, and the gain shows up most at the top end. STEP UP followed 1,407 adults without diabetes for 72 weeks, with an average starting weight of about 249 lb (113 kg)⁴.

That last row is the real story: roughly one in three people on 7.2 mg lost a quarter of their body weight, about double the rate on 2.4 mg².

People with type 2 diabetes lost less, which is typical with GLP-1 drugs. In STEP UP T2D, 7.2 mg produced 13.2% loss versus 3.9% on placebo⁵.

Are the side effects worse at 7.2 mg?

Somewhat, and one is new to most people. Here is the label's comparison³:

The one to know about is dysesthesia: skin that feels sensitive, tingly, painful or burning. It hit about 1 in 5 people on 7.2 mg. The FDA says it usually went away on its own or with a lower dose, and that the agency is still looking into it¹. If you notice it, tell your prescriber rather than pushing through. Stepping back to 2.4 mg is a normal option.

Nausea and constipation barely moved from 2.4 mg. If you got through the ladder, the jump to HD usually feels like a small step, not a restart.

How much does Wegovy HD cost?

On NovoCare's self-pay price list, read October 4, 2026, Wegovy HD is $399 a month, $50 more than the $349 for 2.4 mg (every semaglutide price is in one table here). There's no intro discount on HD: the $199 offer covers only a new patient's first two fills at 0.25 or 0.5 mg. Our NovoCare pharmacy review covers how ordering works.

A few notes on that table:

• •Insurance. HD launched in April 2026 through the same channels as Wegovy, including retail pharmacies, select telehealth and GoodRx². Whether your plan covers 7.2 mg is a separate question from 2.4 mg, so ask.
• •TrumpRx doesn't show which doses its $199 Wegovy price covers. Confirm the dose before you count on it.
• •A year of HD on self-pay is about $4,800, against about $4,200 at 2.4 mg.

For every way to lower the bill, see our Wegovy cost and savings guide.

Can you get 7.2 mg compounded?

Not as an FDA-approved product. Wegovy HD exists only as Novo's pen. Compounded semaglutide is not FDA-approved, and no compounded version was tested in STEP UP. Read where compounded semaglutide stands legally before going that route, and don't raise a compounded dose on your own.

If price is what pushes you toward compounding, our cheapest semaglutide board lists current prices with what each includes.

Wegovy HD vs Zepbound: which goes further?

On paper they are close, but no trial has tested them against each other. Zepbound (tirzepatide) beat Wegovy 2.4 mg head to head in SURMOUNT-5: 20.2% vs 13.7% at 72 weeks⁶. Wegovy HD's 20.7% comes from a different trial with different people, so don't read the two numbers as a match. Our Wegovy vs Zepbound comparison lays out the head-to-head results and prices dose by dose.

Price is close too: TrumpRx lists Zepbound from $299 a month⁷. Our semaglutide vs tirzepatide comparison covers the rest.

The bottom line

Wegovy HD is for people already on 2.4 mg who need more. It adds about three points of average loss and doubles the odds of losing a quarter of your weight. The price is $50 a month more on self-pay, and about 1 in 5 people notice skin sensitivity. If you're stuck at 2.4 mg, raise HD with your prescriber. Then ask whether your insurance treats it as a separate drug.